Introduction
Chronic pain (CP) has a major impact on physical, emotional and cognitive function, on social and family life, and on the ability to work 1 . CP of moderate to severe intensity occurs in 19% of adult Europeans, seriously affecting the quality of their social and working lives [2] [3] [4] . Common chronic pain conditions affect a large percentage of the population in both developed and developing countries of the world 5 . Additionally, CP combined with increased mortality requires a deeper look at it as a public health problem 4 . The majority of patients with CP are treated by their general practitioner (GP). Only a small percentage is under the care of pain specialists 6 . Therefore, it is of extreme importance for GPs to be able to apply unique therapeutic guidelines and evaluate the effect of applied therapy in their patients. Numerous studies indicate the need of changes in the treatment of CP in family medicine [7] [8] [9] [10] . Comprehensive evaluation of any chronic pain condition requires complete history of the pain, physical examination, specific diagnostic tests, and the application of chronic pain assessment tools 11, 12 . Pain assessment is the basis of clinical research and Having outcome measures that are practical enough to be applied to all patients is also important for everyday clinical practice. These measures should be comprehensive in order to be used in the evaluation of the patient's complaints and the physician's recommendations 11 . Pain intensity rating, quality of sleep, and patient ratings of improvement or worsening of the pain condition using the Patients' Global Impression of Change scale (PGIC) are all parts of the recommended tools to evaluate chronic pain. Despite the above, the fact is that these measures are very rarely used by GPs in their everyday clinical practice, but are mainly used as part of clinical trials. Not only do pain scales provide a recognized and validated method for tracking changes in pain intensity and the effectiveness of treatments, but they will also signal to the patient that the pain is taken seriously. The research by Breivik et al. 2 from 2006 showed that only 9% of respondents confirmed that their doctor used a pain scale.
Sleep disturbance is perhaps one of the most common complaints of patients with chronic pain conditions. Experimental studies of healthy persons and cross-sectional studies of clinical populations suggest the possibility that the interaction between sleep disturbances and pain is reciprocal, so that pain disrupts the continuity and quality of sleep, and poor sleep exacerbates the pain 13, 14 . Various instruments are effective for measuring sleep disorders. Among the instruments used in clinical trials to examine sleep disturbances in patients with pain, the Pittsburgh Sleep Quality Index (PSQI) and the Medical Outcomes Study (MOS) sleep scale may be the best choice 15 . The sleep quality numerical rating scale can be used in everyday clinical practice. Assessment of the complete quality of sleep can be estimated by using this scale, and it is often employed to evaluate analgesic effects in patients with fibromyalgia 15 . The PGIC scale is recommended by IMMPACT for use in studies of chronic pain as a basic measure of global improvement in treatment. PGIC enables sensitive and easily-evaluated patient estimates in terms of the importance of deterioration and improvement.
Respondents use this scale with seven possible answers (a seven-point rating scale): very significant improvement, significant improvement, minimal improvement, no change, minimal deterioration, significant deterioration, and very significant deterioration 12 . The aim of our study was to show the role of tools in the evaluation of chronic pain (PI-NRS, singleitem Sleep Quality Numerical Rating Scale, PGIC) in everyday clinical practice of GPs, their influence on the assessment of therapeutic effect, and the possible need of change in therapeutic strategy. The secondary objective was to investigate the mutual effect of pain intensity and quality of sleep in the PGIC in certain groups of CP patients.
Patients and Methods
The study was done by analyzing the electronic database of the first examination of all patients treated at the Clinic for Pain and Palliative Medicine, Karlovac General Hospital in the period from September 24, 2008 to December 8, 2011. All patients were referred by their GPs due to chronic pain of malignant or benign origin. The research was given approval by the local ethics committee. Karlovac General Hospital is a county hospital in the Republic of Croatia with a catchment population of about 70,000. The proportion of people aged 65 and over in the total population of Karlovac County is 19.93% (15.62% in Croatia), and Karlovac County ranks among the counties with the oldest population in Croatia. Seventy-six teams of family physicians provide care for the given population.
The analysis included a total of 1090 patients. Data on the age, gender, and diagnosis of CP condition were collected and analyzed for each patient. Following the initial diagnoses by family physicians, patients were divided into five groups, as follows: musculoskeletal pain, headaches, neuropathic pain, low back pain, and malignant pain. In order to evaluate the effectiveness of previous therapy, the strongest pain a week prior to the examination was recorded at the initial examination, as well as the quality of sleep and PGIC. All analyzed data are required parts of the patient medical records collected by our outpatient clinic personnel.
The severity of chronic pain was measured using a numerical scale for pain on an 11-point numerical Mirjana Lončarić-Katušin et al.
Chronic pain assessment tools pain intensity rating scale (PI-NRS), where 0 means no pain and 10 the worst possible pain. Taking into account the PI-NRS, patients were divided into four groups, as follows: no pain (0), mild pain (1-3), medium-severe pain (4-6), and very strong pain (7) (8) (9) (10) . A single-item scale was used to assess the overall quality of sleep. Patients reported the quality of their sleep on an 11-point numerical rating scale ranging from 0 (best possible sleep) to 10 (worst possible sleep). Given the quality of sleep, patients were divided into four groups, as follows: no sleep disturbances (0), mild sleep disturbance (1-3), mild to moderate sleep disturbance (4-6), and very strong sleep disturbance (7) (8) (9) (10) The mean strongest pain a week prior to the examination (PI-NRS) was 8.3±1.8. Eight hundred and forty-eight (77.80%) patients graded it as very strong pain, 176 (16.10%) as medium-severe pain and 11 (1.00%) as mild pain. Data on the severity of pain were missing for 55 (5.00%) patients.
The mean quality of sleep on the 11-point numerical rating scale was 6.8±1.9. Very strong quality of sleep disorder was present in 627 (57.50%), medium to mild in 244 (22.40%), and mild in 68 (20.6%) patients. None of the patients was free from sleep quality disruption. The overall improvement over therapy previously administered by their family doctor (PGIC) was rated as improved by 0.60%, no change by 34.90% and deteriorated by 47.80% of patients. Data were missing for 16.80% of patients. Table 2 shows comparison of the values measured in groups with sleep quality disorder and categorical values (c 2 -test with Yates correction). It is clear that medium-strong and strong sleep quality disorders were not significantly more present in females (p=0.069), but had a higher incidence in the >65 age group (p=0.007). Patients who rated their PGIC as aggravated had a significantly worse sleep quality (p=0.001) compared to those whose PGIC was rated as an improvement or no change. Medium-strong and severe sleep disturbance was more common in patients with musculoskeletal pain, neuropathic pain and back pain, whereas patients with headache had mild sleep disorder. The severity of pain did not affect the severity of sleep quality disorders. All patients with severe pain complained equally of all categories of sleep quality disorders. Table 3 shows correlation of strongest measured pain scores and sleep with PGIC compared to diagnosis by Pearson correlation coefficient. There was a significant negative correlation between the strongest measured pain (r=-0431, p<0.001) and sleep scores (r=-0230, p<0.001) with PGIC in musculoskeletal pain. A significant negative correlation between the strongest measured pain (r=-0336, p<0.001) and sleep score (r=-0230, p<0.001) with PGIC was found in neuropathic pain. A significant negative correlation between the intensity of pain and PGIC was found for low back pain (r=-0390, p<0.001) and malignant pain (r=-0445, p<0.001), whereas there was no significant correlation with the quality of sleep and PGIC for these diagnoses. There was no correlation between headaches and PI-NRS and quality of sleep with PGIC.
Discussion
Our study showed that chronic pain usually occurred in older age groups. The mean age of our patients was 62.3±15.3 years, which was somewhat higher than the age analyzed in other studies available 2, 5, 16 . The reason for this is probably the older age structure in our county. Likewise, CP was more common in women (65.50%), which is comparable with the literature 2, 5 . Considering the causes of CP, in our patients the most common one was musculoskeletal pain (29.00%), followed by neuropathic pain (23.20%) and low back pain (20.60%). These results are consistent with the research by Sjøgren et al. 17 , which showed the musculoskeletal pain (66.8%) to be the most common cause of CP conditions. However, Tsang et al. 5 concluded that common pain conditions affected a large percentage of people in both developed and de- veloping countries, and back pain and headache were most common, with a higher incidence of CP conditions in women and older age groups. The mean strongest pain a week before the examination (PI-NRS) in our patients was 8.3±1.8. Very strong pain after the treatment administered by the GP was described by 77.80% of patients. Breivik et al. 2 report on one of five adult Europeans on average to suffer from CP, which is moderate in two-thirds and severe in one-third of cases. This suggests substantial underestimation in the treatment of CP in family medicine, poor therapeutic approach, and the need of education in the use of treatment guidelines and tools to evaluate CP.
Many studies indicate a connection between CP and sleep quality 13, 18, 19 . Among the many symptoms associated with pain, significant sleep disorder is one of the most common. It occurs in at least 50% of CP patients. Sleep disorder involves a combination of problems in initiating sleep, as well as maintenance or benefit of sleep. There is considerable evidence that inadequate sleep contributes to pain and vice versa. The fact is that the treatment of pain in clinical trials is combined with reduction of insomnia, daytime sleepiness, and suffering 15 . Sleep disorder has a bidirectional relationship with other features of CP. Previous clinical studies suggest that sleep and rest are frequently disturbed in patients with CP. Up to 88.9% of patients had at least one problem with sleep. Disruption of sleep correlates with stronger pain, depression, disability, and physical symptoms 19, 20 . In order to evaluate the complete quality of sleep, we used a single-item sleep quality numerical rating scale in our study. Easy applicability makes it a suitable tool to evaluate the quality of sleep in everyday clinical practice. All our subjects had a sleep quality disorder. The mean quality of their sleep on an 11-point numerical rating scale was 6.8±1.9. Very strong disorder in the quality of sleep was present in 627 (57.50%), medium-strong in 244 (22.40%), and mild in 68 (20.6%) patients. Disruption of sleep quality was significantly present in patients aged over 65 (p=0.007), those with musculoskeletal pain, neuropathic pain, back pain, and those who had their PGIC evaluated as deteriorating (p=0.001). These data indicate the need of strategies in the treatment of CP, which should include evaluation and treatment of sleep quality correlated with age, gender, and the cause of CP. Goral et al. 14 have shown that chronic pain itself, or as a comorbidity with depressive and anxiety disorders, is associated with increased likelihood of sleep problems. Patients with CP have a two-to three-fold greater likelihood of sleep problems than those who do not suffer from CP or psychiatric disorders. The strong association of pain, depression, anxiety symptoms and sleep disorders suggests that some patients with pain require a comprehensive strategy with the aim of treating all three problems. Available clinical trials indicate that a significant number of patients who suffer from CP are not pleased with their examination, diagnosis, or treatment methods offered 2, 17 . The PGIC is recommended by IMMPACT for use in the research on chronic pain as a basic measure of global improvements in treatment, or as the main outcome measure of global improvement in therapy 12 . Even using this tool to evaluate CP, 47.80% of our respondents estimated PGIC on 'previously conducted therapy with your GP' as aggravation.
It is the effectiveness of therapy, as well as the satisfaction of patients, which are considered essential outcomes of CP treatment. Correlation coefficients have shown that the PGIC is under strong negative impact of pain intensity in patients with musculoskeletal pain, neuropathic pain, low back pain, and malignant pain. That is, the absence of pain is one of the leading causes of PGIC worsening and, with headaches, there is no link between the PI-NRS and quality of sleep with PGIC. This supports the concept that the level of pain is the leading component of the global response of patients that integrates the effect of therapy (treatment), side effects, and patient expectations.
This concept was also proven by Farrar and Young 21 . Data collected from 2724 patients from 10 placebo-controlled clinical trials of pregabalin in diabetic polyneuropathy, post-herpetic neuralgia, low back pain, fibromyalgia, and osteoarthritis showed close correlation between changes in PI-NRS and the PGIC. These serve as an information that facilitates comparison of results between studies, but also helps determine the value of a given therapy in clinical practice. Equally so, by using Pearson correlation coefficient in our results, we showed the PGIC as a global outcome measure of improvements in therapy to be under strong negative impact of poor quality of sleep in patients with musculoskeletal and neuro-Mirjana Lončarić-Katušin et al.
Chronic pain assessment tools pathic pain. There are only a small number of clinical trials showing that the experience of pain and other comorbid symptoms affects PGIC 21, 22 . In a study investigating the interaction between changes in pain, depressive mood, physical function, vitality, sleep disorders, cognitive complaints, and PGIC in 1260 participants with fibromyalgia who had completed one of two clinical trials of safety and efficacy of milnacipran, Geisser et al. 22 demonstrated a very strong correlation between changes in clinical status and PGIC in many of these relationships. Therefore, it is likely that changes in other symptoms, along with pain perception, contribute to global improvement because of the intervention. The authors' findings suggest that the perception of improved clinical status is largely made up of a set of clinical parameters out of which pain is the most important.
Conclusion
Chronic pain is a disorder commonly encountered by the GPs, and the aging of the population will result in an increased prevalence of this diagnosis. For a comprehensive approach to treating CP by GPs, together with the application of clinical guidelines, it is important that clinicians evaluate clinical outcomes of treatment in a standardized framework. Tools to evaluate CP in daily clinical practice must be practical enough to evaluate everything the patients report and to provide clinicians with a comprehensive therapeutic approach. Subsequent studies should evaluate those most applicable for the treatment of CP in family medicine.
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